Trials / Completed
CompletedNCT04859881
Risk Factors for Barotrauma in COVID-19
Risk Factors Associated With Barotrauma in COVID-19 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 262 (actual)
- Sponsor
- Hospital General Ajusco Medio · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Barotrauma in mechanical ventilation (MV) is defined as lung damage attributable to the application of high airway pressure and is one of the potential mechanisms of ventilator-induced lung injury (VILI). Previous studies have shown an increased mortality in patients with barotrauma under MV; pneumothorax (PTX) being the most common presentation, but it can also present as pneumomediastinum (PM) with or without PTX, with extension to soft tissue as subcutaneous emphysema or even as pneumo-retroperitoneum and pneumo-scrotum. Traditionally, underlying lung disease or age are known risk factors for non-trauma related barotrauma. However, in patients with novel coronavirus disease (COVID-19), the incidence of this complication is more common than in non-infected patients, as recently reported. Since little is known regarding which are the main risk factors for these events to develop, most pathophysiological mechanisms remain unexplained. The aim of this study was to determine the risk factors for developing barotrauma in patients under MV with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). Secondary objectives were to determine the incidence of barotrauma and its association with mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-01-31
- Completion
- 2021-01-31
- First posted
- 2021-04-26
- Last updated
- 2021-04-26
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04859881. Inclusion in this directory is not an endorsement.